99 related articles for article (PubMed ID: 17050077)
1. Pax-5 expression in nonhematopoietic tissues.
Torlakovic E; Slipicevic A; Robinson C; DeCoteau JF; Alfsen GC; Vyberg M; Chibbar R; Flørenes VA
Am J Clin Pathol; 2006 Nov; 126(5):798-804. PubMed ID: 17050077
[TBL] [Abstract][Full Text] [Related]
2. B-cell specific activation protein encoded by the PAX-5 gene is commonly expressed in merkel cell carcinoma and small cell carcinomas.
Dong HY; Liu W; Cohen P; Mahle CE; Zhang W
Am J Surg Pathol; 2005 May; 29(5):687-92. PubMed ID: 15832095
[TBL] [Abstract][Full Text] [Related]
3. Pulmonary Carcinoids and Low-Grade Gastrointestinal Neuroendocrine Tumors Show Common MicroRNA Expression Profiles, Different from Adenocarcinomas and Small Cell Carcinomas.
Yoshimoto T; Motoi N; Yamamoto N; Nagano H; Ushijima M; Matsuura M; Okumura S; Yamaguchi T; Fukayama M; Ishikawa Y
Neuroendocrinology; 2018; 106(1):47-57. PubMed ID: 28208131
[TBL] [Abstract][Full Text] [Related]
4. Thyroid transcription factor-1 is expressed in extrapulmonary small cell carcinomas but not in other extrapulmonary neuroendocrine tumors.
Agoff SN; Lamps LW; Philip AT; Amin MB; Schmidt RA; True LD; Folpe AL
Mod Pathol; 2000 Mar; 13(3):238-42. PubMed ID: 10757334
[TBL] [Abstract][Full Text] [Related]
5. PAX-5 expression in pulmonary neuroendocrine neoplasms: its usefulness in surgical and fine-needle aspiration biopsy specimens.
Sica G; Vazquez MF; Altorki N; Port J; Lee PC; Liu Y; Hyjek E; Saqi A
Am J Clin Pathol; 2008 Apr; 129(4):556-62. PubMed ID: 18343782
[TBL] [Abstract][Full Text] [Related]
6. CD200 Expression in Neuroendocrine Neoplasms.
Love JE; Thompson K; Kilgore MR; Westerhoff M; Murphy CE; Papanicolau-Sengos A; McCormick KA; Shankaran V; Vandeven N; Miller F; Blom A; Nghiem PT; Kussick SJ
Am J Clin Pathol; 2017 Sep; 148(3):236-242. PubMed ID: 28821198
[TBL] [Abstract][Full Text] [Related]
7. Differential retinoblastoma protein expression in neuroendocrine tumors of the lung. Potential diagnostic implications.
Cagle PT; el-Naggar AK; Xu HJ; Hu SX; Benedict WF
Am J Pathol; 1997 Feb; 150(2):393-400. PubMed ID: 9033254
[TBL] [Abstract][Full Text] [Related]
8. Value of PAX 8 immunostaining in tumor diagnosis: a review and update.
Ordóñez NG
Adv Anat Pathol; 2012 May; 19(3):140-51. PubMed ID: 22498579
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of somatostatin receptor subtype expression in human neuroendocrine tumors using two sets of new monoclonal antibodies.
Lambertini C; Barzaghi-Rinaudo P; D'Amato L; Schulz S; Nuciforo P; Schmid HA
Regul Pept; 2013 Nov; 187():35-41. PubMed ID: 24188818
[TBL] [Abstract][Full Text] [Related]
10. Paired Box 5 (PAX5) Expression in Poorly Differentiated Neuroendocrine Carcinoma of the Gastrointestinal and Pancreatobiliary Tract: Diagnostic and Potentially Therapeutic Implications.
Ainechi S; Mann SA; Lin J; Patil D; Sheehan CE; Yang Z; Zuo C; Lee H
Appl Immunohistochem Mol Morphol; 2018 Sep; 26(8):545-551. PubMed ID: 27941564
[TBL] [Abstract][Full Text] [Related]
11. PAX8 is expressed in pancreatic well-differentiated neuroendocrine tumors and in extrapancreatic poorly differentiated neuroendocrine carcinomas in fine-needle aspiration biopsy specimens.
Haynes CM; Sangoi AR; Pai RK
Cancer Cytopathol; 2011 Jun; 119(3):193-201. PubMed ID: 21328566
[TBL] [Abstract][Full Text] [Related]
12. Alterations in the expression of p53, KLF4, and p21 in neuroendocrine lung tumors.
Naranjo Gómez JM; Bernal JF; Arranz PG; Fernández SL; Roman JJ
Arch Pathol Lab Med; 2014 Jul; 138(7):936-42. PubMed ID: 24978920
[TBL] [Abstract][Full Text] [Related]
13. [Standardization in pathologic diagnosis of gastrointestinal and pancreatic neuroendocrine tumors].
Zheng J
Zhonghua Bing Li Xue Za Zhi; 2010 Dec; 39(12):793-5. PubMed ID: 21215092
[No Abstract] [Full Text] [Related]
14. Thyroid transcription factor-1: immunohistochemical evaluation in pulmonary neuroendocrine tumors.
Folpe AL; Gown AM; Lamps LW; Garcia R; Dail DH; Zarbo RJ; Schmidt RA
Mod Pathol; 1999 Jan; 12(1):5-8. PubMed ID: 9950155
[TBL] [Abstract][Full Text] [Related]
15. Alteration of the E-cadherin/beta-catenin cell adhesion system is common in pulmonary neuroendocrine tumors and is an independent predictor of lymph node metastasis in atypical carcinoids.
Pelosi G; Scarpa A; Puppa G; Veronesi G; Spaggiari L; Pasini F; Maisonneuve P; Iannucci A; Arrigoni G; Viale G
Cancer; 2005 Mar; 103(6):1154-64. PubMed ID: 15712207
[TBL] [Abstract][Full Text] [Related]
16. The PAX5 oncogene is expressed in N-type neuroblastoma cells and increases tumorigenicity of a S-type cell line.
Baumann Kubetzko FB; Di Paolo C; Maag C; Meier R; Schäfer BW; Betts DR; Stahel RA; Himmelmann A
Carcinogenesis; 2004 Oct; 25(10):1839-46. PubMed ID: 15155532
[TBL] [Abstract][Full Text] [Related]
17. [Primary gastric endocrine tumors].
Liu SM; Liu XY; Zou SM; Wei GL; Sun YT
Zhonghua Bing Li Xue Za Zhi; 2003 Feb; 32(1):38-42. PubMed ID: 12760802
[TBL] [Abstract][Full Text] [Related]
18. Expression of an activated mammalian target of rapamycin (mTOR) in gastroenteropancreatic neuroendocrine tumors.
Shida T; Kishimoto T; Furuya M; Nikaido T; Koda K; Takano S; Kimura F; Shimizu H; Yoshidome H; Ohtsuka M; Tanizawa T; Nakatani Y; Miyazaki M
Cancer Chemother Pharmacol; 2010 Apr; 65(5):889-93. PubMed ID: 19657638
[TBL] [Abstract][Full Text] [Related]
19. [Gastrointestinal and pancreatic neuroendocrine tumors: a clinicopathologic and immunohistochemical study].
Sun LM; Qiu XS; Wang EH
Zhonghua Bing Li Xue Za Zhi; 2012 Oct; 41(10):696-7. PubMed ID: 23302313
[No Abstract] [Full Text] [Related]
20. Analysis of p53, K-ras-2, and C-raf-1 in pulmonary neuroendocrine tumors. Correlation with histological subtype and clinical outcome.
Przygodzki RM; Finkelstein SD; Langer JC; Swalsky PA; Fishback N; Bakker A; Guinee DG; Koss M; Travis WD
Am J Pathol; 1996 May; 148(5):1531-41. PubMed ID: 8623922
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]